Hans van Houte
Director of Finance/CFO en NURIX THERAPEUTICS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Hans van Houte is currently the Chief Financial Officer at Nurix Therapeutics, Inc. He previously held positions as the Chief Accounting Officer, Treasurer & Controller at Vertex Pharmaceuticals, Inc., Vice President-Finance & Operations at Emergent Product Development Seattle, Chief Financial Officer at Igenica Biotherapeutics, Inc., and Managing Partner at Bionation LLC.
Mr. van Houte completed his undergraduate degree at Babson College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NURIX THERAPEUTICS, INC.
0.14% | 21/03/2024 | 68 333 ( 0.14% ) | 1 M $ | 31/03/2024 |
Cargos activos de Hans van Houte
Empresas | Cargo | Inicio |
---|---|---|
NURIX THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2016 |
Antiguos cargos conocidos de Hans van Houte.
Empresas | Cargo | Fin |
---|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Director of Finance/CFO | - |
Bionation LLC | Corporate Officer/Principal | - |
VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - |
Formación de Hans van Houte.
Babson College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
NURIX THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Bionation LLC |
- Bolsa de valores
- Insiders
- Hans van Houte